SCHEMBL9456344

SCHEMBL9456344

O=C1CC(CCl)CN1Cc1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.62
TSHR P16473 1/20 0.62
DPP4 P27487 2/20 0.51
PDE4A P27815 1/20 0.48
PDE4B Q07343 1/20 0.48
PDE4C Q08493 1/20 0.48
PDE4D Q08499 1/20 0.48
SMN1; SMN2 Q16637 3/20 0.47
ALDH1A1 P00352 2/20 0.47
KMT2A Q03164 1/20 0.46
HTT P42858 1/20 0.46
NPC1 O15118 1/20 0.45
LMNA P02545 1/20 0.45
GLA P06280 1/20 0.45
MAPT P10636 1/20 0.45
RAB9A P51151 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7436181 0.87 HPGD (0.62) HPGDTSHRDPP4PDE4APDE4B
SCHEMBL20722377 0.85 HPGD (0.60) HPGDTSHRDPP4PDE4APDE4B
SCHEMBL3124428 0.85 HPGD (0.60) HPGDTSHRDPP4PDE4APDE4B
SCHEMBL21704253 0.85 HPGD (0.60) HPGDTSHRDPP4PDE4APDE4B
SCHEMBL3240700 0.85 HPGD (0.60) HPGDTSHRDPP4PDE4APDE4B
SCHEMBL13036597 0.85 HPGD (0.60) HPGDTSHRDPP4PDE4APDE4B
Nebracetam SCHEMBL195354 0.85 HPGD (0.60) HPGDTSHRDPP4PDE4APDE4B
SCHEMBL15291862 0.84 HPGD (0.59) HPGDTSHRDPP4PDE4APDE4B
SCHEMBL9437301 0.83 HPGD (0.57) HPGDTSHRDPP4PDE4APDE4B
SCHEMBL4298321 0.83 HPGD (0.57) HPGDTSHRDPP4SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5217967-A Tricyclic antidepressant co-administered with a N-benzylpyrrolidin-2-one BOEHRINGER INGELHEIM GMBH (DE) 1993-06-08 US disclosed
US-5149808-A Nootropics, antihypoxic agents BOEHRINGER INGELHEIM KG (DE) 1992-09-22 US disclosed
EP-0266563-B1 USE OF 1-BENZYL-AMINO-ALKYL-PYRROLIDINONES AS ANTIDEPRESSANTS BOEHRINGER INGELHEIM KG (DE) 1992-01-29 EP disclosed
EP-0280290-B1 AGENT HAVING AN ANTIDEPRESSIVE ACTIVITY BOEHRINGER INGELHEIM KG (DE) 1992-01-08 EP disclosed
US-5073671-A Nootropic and antihypoxic agents BOEHRINGER INGELHEIM KG (DE) 1991-12-17 US disclosed
US-4996224-A 1-benzyl-4- or 5-pyrrolidinomethyl-pyrrolidin-2-ones and nootropic method of use thereof BOEHRINGER INGELHEIM KG (DE) 1991-02-26 US disclosed
US-4954516-A Use of 1-benzyl-aminoalkyl-pyrrolidinones as antidepressants BOEHRINGER INGELHEIM KG (DE) 1990-09-04 US disclosed
US-4931435-A TRICYCLIC ANTIDEPRESSANT WITH BENZYLPYRROLIDINONE; SIDE EFFECT REDUCTION BOEHRINGER INGELHEIM KG (DE) 1990-06-05 US disclosed
US-4912129-A Administering to humans BOEHRINGER INGELHEIM GMBH (DE) 1990-03-27 US disclosed
US-4833140-A ANTIHYPOXIC AGENTS BOEHRINGER INGELHEIM KG (DE) 1989-05-23 US disclosed
EP-0136658-B1 -1-BENZYL-AMINOALKYL-PYRROLIDINONES AND THEIR ADDITION SALTS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOUNDS CONTAINING THEM BOEHRINGER INGELHEIM KG (DE) 1989-04-26 EP disclosed
US-4812453-A Use of 1-benzyl-aminoalkyl-pyrrolidinones as antidepressants BOEHRINGER INGELHEIM KG (DE) 1989-03-14 US disclosed
EP-0280290-A2 Agent having an antidepressive activity BOEHRINGER INGELHEIM KG (DE) 1988-08-31 EP disclosed
US-4767759-A ANTIHYPOXICS BOEHRINGER INGELHEIM KG (DE) 1988-08-30 US disclosed
EP-0266563-A2 Use of 1-benzyl-amino-alkyl-pyrrolidinones as antidepressants BOEHRINGER INGELHEIM KG (DE) 1988-05-11 EP disclosed
EP-0136658-A2 -1-Benzyl-aminoalkyl-pyrrolidinones and their addition salts, process for their preparation and pharmaceutical compounds containing them BOEHRINGER INGELHEIM KG (DE) 1985-04-10 EP disclosed